FDA Recalls Subpotent Nandrolone Decanoate Compounding Ingredient from Fagron
Fagron Inc. initiated a voluntary recall of 68 containers of Nandrolone Decanoate USP in March 2022 after the product was found subpotent, containing less active ingredient than labeled. The recall affects compounding pharmacies nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class III voluntary recall with no reported illnesses or injuries. It involves subpotency in a compounding ingredient, consistent with the 'voluntary precautionary recalls' criterion for Moderate severity.
Plain-English summary
Fagron, Inc. is recalling 68 containers of Nandrolone Decanoate, USP, a steroid ingredient used by pharmacies to prepare prescription medications. Each container holds 1 kilogram (NDC 51552-1564-07).
The company initiated this voluntary recall in March 2022 after determining that batches of the product contained less active ingredient than labeled. Affected lot numbers are 18H02-U02-044977, 18H02-U02-046140, 18L12-U02-050572 (expiring 10/31/2022) and 18L12-U02-050308, 18L12-U02-000951 (expiring September 2023). The product was distributed nationwide.
Compounding pharmacies that received this ingredient may have used it to prepare patient medications without knowing the drug was subpotent. Patients who received such medications should consult their pharmacy or healthcare provider if they have concerns about treatment efficacy. The FDA classified this as a Class III recall, which was terminated in July 2024.
The recalled product
- Product
- Nandrolone Decanoate, USP, 1 kg per plastic container, Rx Only, For Prescription Compounding, Fagron, Inc. 2400 Pilot Knob Rd., St Paul, MN 55120. NDC 51552-1564-07
- Manufacturer
- Fagron, Inc
- Category
- Drug — Compounding Ingredient
- Hazard
- subpotency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot #: 18H02-U02-044977
- 18H02-U02-046140
- 18L12-U02-050572
- Exp. Date 10/31/2022
- 18L12-U02-050308
- 18L12-U02-000951
- Exp. Date Sep 2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27